Display Settings:

Format

Send to:

Choose Destination
    Br J Psychiatry. 1991 Nov;159:709-12.

    The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?

    Source

    Department of Psychiatry, McMaster University Medical Centre, Hamilton, Ontario, Canada.

    Abstract

    In a prospective study of 20 patients with NMS, those who received dantrolene (2 patients) or bromocriptine (2 patients) or both (4 patients) tended to have a more prolonged course of illness and a greater incidence of sequelae than those treated with supportive care alone. These results do not indicate a useful role for dantrolene or bromocriptine in the treatment of NMS.

    PMID:
    1843801
    [PubMed - indexed for MEDLINE]

    LinkOut - more resources

    Other Literature Sources

    Molecular Biology Databases

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk